Linseed Oil

Why It Matters for Longevity

Linseed (flaxseed) oil is the most concentrated plant-based source of alpha-linolenic acid (ALA), an essential omega-3 fatty acid at approximately 55% of fatty acids by weight. ALA is not synthesized endogenously and must be obtained from diet; it serves as a precursor to the long-chain marine omega-3s EPA and DHA, though conversion is limited (~8% to EPA, <0.5% to DHA in humans).

Daily supplementation with flaxseed oil significantly altered red blood cell n-3 fatty acid composition in a dose-dependent manner, with measurable incorporation of ALA-derived EPA into cell membranes -- demonstrating meaningful biological uptake from dietary linseed oil even given limited conversion efficiency (Barceló-Coblijn and Murphy, 2008, Am J Clin Nutr).

Flaxseed oil consumption reduces inflammatory markers (CRP, IL-6, TNF-alpha) and improves endothelial function; regular ALA intake is associated with reduced cardiovascular disease risk through anti-inflammatory mechanisms independent of EPA/DHA conversion (Bloedon and Szapary, 2004, Nutr Rev).

ALA from flaxseed oil is partially converted to EPA (~8%) and DHA (<0.5%) in humans; on plant-based longevity diets where marine omega-3 sources are limited, regular high-ALA supplementation can produce meaningful EPA levels in plasma and cell membranes (Brenna et al., 2009, Prostaglandins Leukot Essent Fatty Acids).

ALA and Cardiovascular Disease Risk

The cardiovascular case for dietary ALA has strengthened considerably over the past decade. A 2022 review of multiple meta-analyses (Sala-Vila et al., 2022, Advances in Nutrition) found that higher ALA consumption was associated with a 10% lower risk of total cardiovascular disease and a 20% reduction in fatal coronary heart disease risk. RCT evidence from three major trials (AlphaOmega, PREDIMED, Lyon Diet Heart Study) showed ALA reduced total cholesterol, LDL cholesterol, triglycerides, and blood pressure. The anti-inflammatory pathway is a key mechanism: ALA competes with arachidonic acid (omega-6) for desaturase enzymes, partially reducing the production of pro-inflammatory eicosanoids. Because this effect is upstream of EPA/DHA, it operates even at low conversion rates.

The omega-3:omega-6 ratio of linseed oil -- approximately 3.5:1 (55 g ALA vs. 15 g linoleic acid per 100 g) -- is exceptional among vegetable oils. Most vegetable oils are heavily weighted toward omega-6; corn oil, for example, has an omega-6:omega-3 ratio of roughly 50:1. This makes linseed oil one of the few plant oils that can meaningfully shift the dietary n-3/n-6 balance in a favourable direction.

Blood Pressure Effects

Multiple meta-analyses have examined whether flaxseed/ALA supplementation lowers blood pressure. A 2016 meta-analysis of 15 RCTs (1,302 participants) by Ursoniu et al. (Clinical Nutrition, PMID 26071633) found that flaxseed supplementation reduced systolic BP by a weighted mean difference of 2.85 mmHg (95% CI: -5.37 to -0.33, p = 0.027) and diastolic BP by 2.39 mmHg (95% CI: -3.78 to -0.99, p = 0.001). Longer interventions (≥12 weeks) produced larger effects. A 2022 meta-analysis focused on flaxseed oil in metabolic syndrome (5 RCTs, 6 intervention arms; Mahmudiono et al., Phytotherapy Research, PMID 35859037) confirmed a significant systolic BP reduction of 3.86 mmHg (95% CI: -7.59 to -0.13, p = 0.04), though the diastolic reduction did not reach significance in this subgroup.

The likely mechanism involves ALA-derived EPA acting on endothelial nitric oxide synthase (eNOS) and reducing thromboxane A2 synthesis, promoting vasodilation. ALA may also independently modulate vascular tone through incorporation into membrane phospholipids, independently of full EPA/DHA conversion.

Storage and Oxidative Stability

Linseed oil's greatest nutritional strength -- its high ALA content -- is also its primary handling vulnerability. With three double bonds, ALA is far more susceptible to oxidative rancidity than monounsaturated or saturated fatty acids. Exposure to heat, light, or oxygen generates peroxidation products that not only eliminate the oil's nutritional value but can introduce harmful aldehydes. Linseed oil has a very low smoke point (~107°C) and should never be heated. Cold-pressed, unrefined linseed oil stored in a sealed dark glass bottle in the refrigerator retains acceptable quality for approximately 6 weeks after opening; flavour deterioration (increasing bitterness) is a reliable indicator of oxidative degradation even before rancidity reaches measurable thresholds.

How to Use It

Use as a finishing oil -- never heat linseed oil as ALA oxidizes rapidly at high temperatures. Add to salads, drizzle over cooked vegetables or grains, or mix into dressings. Store in dark glass refrigerated and use within 6 weeks of opening. During the Longevity Diet's FMD protocol, linseed oil is used three times daily as an essential fatty acid supplement during caloric restriction.

What to Pair It With

Flavor Profile

Nutty, slightly bitter, earthy. Aroma is nutty and grassy. Texture is liquid oil with thin viscosity. Best used raw as a finishing oil; oxidizes quickly when exposed to heat or air.

The Science

• Barceló-Coblijn and Murphy, 2008, Am J Clin Nutr: Flaxseed oil supplementation dose-dependently altered red blood cell n-3 fatty acid composition, with measurable EPA incorporation -- demonstrating meaningful biological uptake of ALA from dietary linseed oil.
• Bloedon and Szapary, 2004, Nutr Rev: Flaxseed oil (ALA) consumption associated with reduced inflammatory markers (CRP, IL-6, TNF-alpha) and improved endothelial function in observational and interventional studies.
• Brenna et al., 2009, Prostaglandins Leukot Essent Fatty Acids: ALA conversion to EPA is approximately 8% in humans; regular high-ALA intake from linseed oil produces meaningful EPA levels in plant-based dieters with limited marine omega-3 sources.
• Sala-Vila et al., 2022, Advances in Nutrition: Review of meta-analyses -- higher ALA intake associated with 10% lower total CVD risk and 20% lower fatal CHD risk; RCT evidence supports LDL, triglyceride, and blood pressure reductions.
• Ursoniu et al., 2016, Clinical Nutrition: Meta-analysis of 15 RCTs (1,302 participants) -- flaxseed supplementation reduced systolic BP by 2.85 mmHg and diastolic BP by 2.39 mmHg; effects larger in trials ≥12 weeks.
• Mahmudiono et al., 2022, Phytotherapy Research: Meta-analysis of 5 RCTs in metabolic syndrome patients -- flaxseed oil reduced systolic BP by 3.86 mmHg (p = 0.04); mechanism likely involves ALA-derived modulation of eNOS and thromboxane A2 synthesis.

References

1. Barceló-Coblijn G, Murphy EJ, et al. Flaxseed oil and fish-oil capsule consumption alters human red blood cell n-3 fatty acid composition: a multiple-dosing trial comparing 2 sources of n-3 fatty acid. Am J Clin Nutr. 2008;88(3):801-809. PMID: 18779299. doi:10.1093/ajcn/88.3.801
2. Bloedon LT, Szapary PO. Flaxseed and cardiovascular risk. Nutr Rev. 2004;62(1):18-27. PMID: 19515737. doi:10.1111/j.1753-4887.2004.tb00030.x
3. Brenna JT, Salem N Jr, Sinclair AJ, Cunnane SC. Alpha-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans. Prostaglandins Leukot Essent Fatty Acids. 2009;80(2-3):85-91. PMID: 27434027. doi:10.1016/j.plefa.2009.01.004
4. Sala-Vila A, Fleming J, Kris-Etherton P, Ros E. Impact of α-Linolenic Acid, the Vegetable ω-3 Fatty Acid, on Cardiovascular Disease and Cognition. Advances in Nutrition. 2022;13(5):1584-1602. PMID: 35170723. doi:10.1093/advances/nmac016
5. Ursoniu S, Sahebkar A, Andrica F, Serban C, Banach M. Effects of flaxseed supplements on blood pressure: A systematic review and meta-analysis of controlled clinical trial. Clinical Nutrition. 2016;35(3):615-625. PMID: 26071633. doi:10.1016/j.clnu.2015.05.012
6. Mahmudiono T, Jasim SA, Karim YS, et al. The effect of flaxseed oil consumption on blood pressure among patients with metabolic syndrome and related disorders: A systematic review and meta-analysis of randomized clinical trials. Phytotherapy Research. 2022;36(10):3766-3774. PMID: 35859037. doi:10.1002/ptr.7566

Key Nutrients